Exencial Wealth Advisors LLC Has $13.06 Million Stock Position in GE HealthCare Technologies Inc. $GEHC

Exencial Wealth Advisors LLC lowered its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.3% during the 2nd quarter, Holdings Channel.com reports. The firm owned 176,329 shares of the company’s stock after selling 7,998 shares during the quarter. Exencial Wealth Advisors LLC’s holdings in GE HealthCare Technologies were worth $13,061,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the stock. Hotchkis & Wiley Capital Management LLC raised its holdings in shares of GE HealthCare Technologies by 3.2% during the first quarter. Hotchkis & Wiley Capital Management LLC now owns 5,751,773 shares of the company’s stock valued at $464,226,000 after purchasing an additional 176,572 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of GE HealthCare Technologies by 49.9% in the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after acquiring an additional 1,711,963 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of GE HealthCare Technologies by 3.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,943,579 shares of the company’s stock worth $398,975,000 after acquiring an additional 157,839 shares during the last quarter. Canada Pension Plan Investment Board raised its holdings in shares of GE HealthCare Technologies by 15.2% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock worth $251,121,000 after acquiring an additional 409,636 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of GE HealthCare Technologies by 3.7% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 3,069,114 shares of the company’s stock worth $247,708,000 after acquiring an additional 109,858 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on GEHC. Barclays began coverage on shares of GE HealthCare Technologies in a report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 target price on the stock. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Tuesday, October 14th. BTIG Research lifted their target price on shares of GE HealthCare Technologies from $87.00 to $89.00 and gave the stock a “buy” rating in a research report on Monday, October 13th. Finally, Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, September 18th. Six research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average price target of $85.20.

GE HealthCare Technologies Trading Up 0.8%

Shares of GEHC stock opened at $76.10 on Wednesday. The company has a 50 day moving average of $74.60 and a 200-day moving average of $72.16. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The firm has a market cap of $34.74 billion, a P/E ratio of 15.59, a PEG ratio of 2.88 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same quarter last year, the business posted $1.00 EPS. GE HealthCare Technologies’s quarterly revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s payout ratio is 2.87%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.